Ortega O - Search Results

1

Changes in body composition parameters in patients on haemodialysis and peritoneal dialysis.

Di-Gioia MC, Gallar P, Rodríguez I, Laso N, Callejas R, Ortega O, Herrero JC, Vigil A. Di-Gioia MC, et al. Among authors: ortega o. Nefrologia. 2012;32(1):108-13. doi: 10.3265/Nefrologia.pre2011.Oct.10938. Nefrologia. 2012. PMID: 22294009 Free article. English, Spanish.

2

Intraperitoneal erythromycin for diabetic gastroparesis in CAPD.

Gallar P, Vigil A, Oliet A, Ortega O, Guijo G. Gallar P, et al. Among authors: ortega o. Perit Dial Int. 1992;12(2):265-6. Perit Dial Int. 1992. PMID: 1586696 No abstract available.

3

[Treatment of the diffuse and focal proliferative forms of lupus nephropathy with intravenous cyclophosphamide. Intravenous cyclophosphamide in systemic lupus erythematosus].

Vigil A, Gallar P, Oliet A, Ortega O, Bajo MA. Vigil A, et al. Among authors: ortega o. Rev Clin Esp. 1995 Aug;195(8):524-9. Rev Clin Esp. 1995. PMID: 7569197 Clinical Trial. Spanish.

4

Choice of dialysis membrane does not influence the outcome of residual renal function in haemodialysis patients.

Caramelo C, Alcázar R, Gallar P, Teruel JL, Velo M, Ortega O, Galera A, Da Silva M. Caramelo C, et al. Among authors: ortega o. Nephrol Dial Transplant. 1994;9(6):675-7. doi: 10.1093/ndt/9.6.675. Nephrol Dial Transplant. 1994. PMID: 7970095 Clinical Trial.

5

Renal failure as a cause of false-positive on metaiodobenzilguanidine (MIBG) scan.

Gallar P, Oliet A, Hernandez E, Vigil A, Ortega O. Gallar P, et al. Among authors: ortega o. Nephrol Dial Transplant. 1993;8(5):481. Nephrol Dial Transplant. 1993. PMID: 8393560 No abstract available.

6

Gastroparesis: an important cause of hospitalization in continuous ambulatory peritoneal dialysis patients and the role of erythromycin.

Gallar P, Oliet A, Vigil A, Ortega O, Guijo G. Gallar P, et al. Among authors: ortega o. Perit Dial Int. 1993;13 Suppl 2:S183-6. Perit Dial Int. 1993. PMID: 8399560

7

[Treatment of idiopathic membranous glomerulonephritis with steroids and immunosuppressors].

Vigil A, Oliet A, Gallar P, Ortega O, Rodríguez Villarreal I. Vigil A, et al. Among authors: ortega o. Nefrologia. 2000 May-Jun;20(3):291-4. Nefrologia. 2000. PMID: 10917007 Free article. Spanish. No abstract available.

8

[Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].

Gallar P, Ortega O, Gutiérrez M, Muñoz M, Hilara L, Oliet A, Rodríguez I, Giménez E, Vigil A. Gallar P, et al. Among authors: ortega o. Nefrologia. 2000 Jul-Aug;20(4):355-61. Nefrologia. 2000. PMID: 11039261 Free article. Spanish.

9

Rate of decline in residual renal fuction is equal in CAPD and automated peritoneal dialysis patients.

Gallar P, Ortega O, Carreno A, Vigil A. Gallar P, et al. Among authors: ortega o. Perit Dial Int. 2000 Nov-Dec;20(6):803-5. Perit Dial Int. 2000. PMID: 11216585 No abstract available.

10

Peritoneal sodium mass removal in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis: influence on blood pressure control.

Ortega O, Gallar P, Carreño A, Gutierrez M, Rodriguez I, Oliet A, Vigil A, Gimenez E. Ortega O, et al. Am J Nephrol. 2001 May-Jun;21(3):189-93. doi: 10.1159/000046246. Am J Nephrol. 2001. PMID: 11423687

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters